Yong Yue1, Arsen Osipov2, Benedick Fraass1, Howard Sandler1, Xiao Zhang3, Nicholas Nissen4, Andrew Hendifar4, Richard Tuli1. 1. Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 2. Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 3. Department of Biostatistics and Bioinformatics, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 4. Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Abstract
BACKGROUND: To stratify risks of pancreatic adenocarcinoma (PA) patients using pre- and post-radiotherapy (RT) PET/CT images, and to assess the prognostic value of texture variations in predicting therapy response of patients. METHODS: Twenty-six PA patients treated with RT from 2011-2013 with pre- and post-treatment 18F-FDG-PET/CT scans were identified. Tumor locoregional texture was calculated using 3D kernel-based approach, and texture variations were identified by fitting discrepancies of texture maps of pre- and post-treatment images. A total of 48 texture and clinical variables were identified and evaluated for association with overall survival (OS). The prognostic heterogeneity features were selected using lasso/elastic net regression, and further were evaluated by multivariate Cox analysis. RESULTS: Median age was 69 y (range, 46-86 y). The texture map and temporal variations between pre- and post-treatment were well characterized by histograms and statistical fitting. The lasso analysis identified seven predictors (age, node stage, post-RT SUVmax, variations of homogeneity, variance, sum mean, and cluster tendency). The multivariate Cox analysis identified five significant variables: age, node stage, variations of homogeneity, variance, and cluster tendency (with P=0.020, 0.040, 0.065, 0.078, and 0.081, respectively). The patients were stratified into two groups based on the risk score of multivariate analysis with log-rank P=0.001: a low risk group (n=11) with a longer mean OS (29.3 months) and higher texture variation (>30%), and a high risk group (n=15) with a shorter mean OS (17.7 months) and lower texture variation (<15%). CONCLUSIONS: Locoregional metabolic texture response provides a feasible approach for evaluating and predicting clinical outcomes following treatment of PA with RT. The proposed method can be used to stratify patient risk and help select appropriate treatment strategies for individual patients toward implementing response-driven adaptive RT.
BACKGROUND: To stratify risks of pancreatic adenocarcinoma (PA) patients using pre- and post-radiotherapy (RT) PET/CT images, and to assess the prognostic value of texture variations in predicting therapy response of patients. METHODS: Twenty-six PA patients treated with RT from 2011-2013 with pre- and post-treatment 18F-FDG-PET/CT scans were identified. Tumor locoregional texture was calculated using 3D kernel-based approach, and texture variations were identified by fitting discrepancies of texture maps of pre- and post-treatment images. A total of 48 texture and clinical variables were identified and evaluated for association with overall survival (OS). The prognostic heterogeneity features were selected using lasso/elastic net regression, and further were evaluated by multivariate Cox analysis. RESULTS: Median age was 69 y (range, 46-86 y). The texture map and temporal variations between pre- and post-treatment were well characterized by histograms and statistical fitting. The lasso analysis identified seven predictors (age, node stage, post-RT SUVmax, variations of homogeneity, variance, sum mean, and cluster tendency). The multivariate Cox analysis identified five significant variables: age, node stage, variations of homogeneity, variance, and cluster tendency (with P=0.020, 0.040, 0.065, 0.078, and 0.081, respectively). The patients were stratified into two groups based on the risk score of multivariate analysis with log-rank P=0.001: a low risk group (n=11) with a longer mean OS (29.3 months) and higher texture variation (>30%), and a high risk group (n=15) with a shorter mean OS (17.7 months) and lower texture variation (<15%). CONCLUSIONS: Locoregional metabolic texture response provides a feasible approach for evaluating and predicting clinical outcomes following treatment of PA with RT. The proposed method can be used to stratify patient risk and help select appropriate treatment strategies for individual patients toward implementing response-driven adaptive RT.
Authors: Ludwig G Strauss; Leyun Pan; Dirk Koczan; Sven Klippel; Krzysztof Mikolajczyk; Cyrill Burger; Uwe Haberkorn; Klaus Schönleben; Hans-Jürgen Thiesen; Antonia Dimitrakopoulou-Strauss Journal: IEEE Trans Med Imaging Date: 2007-06 Impact factor: 10.048
Authors: Andrew J Buckler; Linda Bresolin; N Reed Dunnick; Daniel C Sullivan; Hugo J W L Aerts; Bernard Bendriem; Claus Bendtsen; Ronald Boellaard; John M Boone; Patricia E Cole; James J Conklin; Gary S Dorfman; Pamela S Douglas; Willy Eidsaunet; Cathy Elsinger; Richard A Frank; Constantine Gatsonis; Maryellen L Giger; Sandeep N Gupta; David Gustafson; Otto S Hoekstra; Edward F Jackson; Lisa Karam; Gary J Kelloff; Paul E Kinahan; Geoffrey McLennan; Colin G Miller; P David Mozley; Keith E Muller; Rick Patt; David Raunig; Mark Rosen; Haren Rupani; Lawrence H Schwartz; Barry A Siegel; A Gregory Sorensen; Richard L Wahl; John C Waterton; Walter Wolf; Gudrun Zahlmann; Brian Zimmerman Journal: Radiology Date: 2011-02-15 Impact factor: 11.105
Authors: K A Bickenbach; M Gonen; Laura H Tang; Eileen O'Reilly; Karyn Goodman; M F Brennan; M I D'Angelica; R P Dematteo; Y Fong; W R Jarnagin; P J Allen Journal: Ann Surg Oncol Date: 2011-12-01 Impact factor: 5.344
Authors: Brendan C Visser; Yifei Ma; Yulia Zak; George A Poultsides; Jeffrey A Norton; Kim F Rhoads Journal: HPB (Oxford) Date: 2012-06-12 Impact factor: 3.647
Authors: Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts Journal: Eur J Cancer Date: 2012-01-16 Impact factor: 9.162
Authors: Kenneth J Biehl; Feng-Ming Kong; Farrokh Dehdashti; Jian-Yue Jin; Sasa Mutic; Issam El Naqa; Barry A Siegel; Jeffrey D Bradley Journal: J Nucl Med Date: 2006-11 Impact factor: 10.057
Authors: Marc A Attiyeh; Jayasree Chakraborty; Alexandre Doussot; Liana Langdon-Embry; Shiana Mainarich; Mithat Gönen; Vinod P Balachandran; Michael I D'Angelica; Ronald P DeMatteo; William R Jarnagin; T Peter Kingham; Peter J Allen; Amber L Simpson; Richard K Do Journal: Ann Surg Oncol Date: 2018-01-29 Impact factor: 5.344
Authors: Sherif B Elsherif; Sanaz Javadi; Ott Le; Nathan Lamba; Matthew H G Katz; Eric P Tamm; Priya R Bhosale Journal: Radiol Imaging Cancer Date: 2022-03
Authors: Craig Parkinson; Kieran Foley; Philip Whybra; Robert Hills; Ashley Roberts; Chris Marshall; John Staffurth; Emiliano Spezi Journal: EJNMMI Res Date: 2018-04-11 Impact factor: 3.138